SCHEMBL25823232

SCHEMBL25823232

ONCCc1ccc(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.64
BCHE P06276 2/20 0.55
MTNR1A P48039 2/20 0.54
MTNR1B P49286 2/20 0.54
KDM4E B2RXH2 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
LMNA P02545 2/20 0.51
HTT P42858 2/20 0.51
ALDH1A1 P00352 1/20 0.51
KMT2A Q03164 3/20 0.49
NPY1R P25929 1/20 0.49
NPY2R P49146 1/20 0.49
FFAR4 Q5NUL3 1/20 0.49
FFAR1 O14842 1/20 0.49
APP P05067 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16843527 0.84 SLC2A1 (0.67) SLC2A1BCHEMTNR1AMTNR1BKDM4E
SCHEMBL7279743 0.83 SLC2A1 (0.80) SLC2A1BCHEKDM4ESMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL11290284 0.83 SLC2A1 (0.59) SLC2A1BCHEMTNR1AMTNR1BKDM4E
SCHEMBL360371 0.82 CYP4F2 (0.63) SLC2A1BCHEMTNR1AMTNR1BKDM4E
SCHEMBL10701257 0.81 SLC2A1 (0.64) SLC2A1BCHEMTNR1AMTNR1BKDM4E
SCHEMBL21473721 0.81 SLC2A1 (0.60) SLC2A1BCHEMTNR1AMTNR1BKDM4E
SCHEMBL10604591 0.80 ALDH1A1 (0.61) SLC2A1MTNR1AMTNR1BSMN1; SMN2LMNA
SCHEMBL7279749 0.80 SLC2A1 (0.89) SLC2A1BCHEKDM4ESMN1; SMN2LMNA
SCHEMBL19194585 0.79 LTA4H (0.64) SLC2A1BCHEMTNR1AMTNR1BKDM4E
SCHEMBL17210775 0.79 CYP4F2 (0.69) BCHEKDM4EALDH1A1KMT2AFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218768-A1 Chemically Coupled Transporter for Low-Hydrophobicity Bioactive Drugs into the Central Nervous System CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS (CONICET) (AR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218768-A1 Chemically Coupled Transporter for Low-Hydrophobicity Bioactive Drugs into the Central Nervous System SLC6A3, SLC18A2, TSPO SLC2A1 48/4885BCHE 330/4885MTNR1A 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.